Pfizer is Lobbying to Thwart Whistleblowers from Exposing Corporate Fraud

Published On: November 29th, 2021

This article features a comment from Kohn, Kohn & Colapinto’s founding partner, Stephen M. Kohn.

Pfizer is among the Big Pharma companies trying to block legislation strengthening whistleblowers’ ability to report corporate fraud. Kohn comments “This is a very concerted lobbying effort that really took our supporters on Capitol Hill by surprise.”

Share This Story, Choose Your Platform!

Latest News & Insights

Rules for Whistleblowers - 3 Ways to Order

New Release

Rules for Whistleblowers

The ultimate guide to blowing the whistle and getting rewarded for doing what's right.

Subscribe for News & Resources

Receive exclusive updates and news from our firm.

This field is for validation purposes and should be left unchanged.